FDA — authorised 28 May 2009
- Application: NDA022308
- Marketing authorisation holder: BAUSCH AND LOMB
- Local brand name: BESIVANCE
- Indication: SUSPENSION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 ISV-403 in United States
FDA authorised ISV-403 on 28 May 2009
Marketing authorisation
Other Ophthalmology approved in United States
Frequently asked questions
Is ISV-403 approved in United States?
Yes. FDA authorised it on 28 May 2009.
Who is the marketing authorisation holder for ISV-403 in United States?
BAUSCH AND LOMB holds the US marketing authorisation.